BioTrinity 2022: Catalysing growth in the life sciences industry
10 Feb 2022
Life Science professionals are invited to attend BioTrinity 2022. A face-to-face event, taking place in London, UK, 26-27 April that will feature two dedicated tracks. The ‘Scientific’ track will focus on seven core therapy areas and the ‘Life Sciences Business’ Programme will feature a keynote from George Freeman MP, with an update on the UK Government Life Sciences Vision.
OBN (UK), the membership organisation that supports the life sciences industry, is delighted to invite Life Science professionals and companies to attend BioTrinity 2022 in London, UK, from 26–27th April. Registration for BioTrinity 2022 now available online
BioTrinity remains one of the only industry conferences being delivered in-person this year and offers a blend of focused scientific updates, targeted business insights, 1-1 partnering opportunities as well as live and in-person networking to promote collaboration across the Life Sciences sector. The event will provide a platform for delegates to connect with experts from industry, academia, and investment, along with global pharmaceutical organisations.
BioTrinity 2022 aims to catalyse growth in the Life Sciences industry by promoting knowledge and information exchange, collaboration, partnering, and networking. The event will include a dedicated ‘Scientific Track’, featuring a focus on seven core therapy areas of Oncology, CNS, Microbiome, Inflammation, Infectious Diseases, Rare Diseases as well as AI and Data & Platform Technology.
A second ‘Life Sciences Business’ presentation track will include discussions and keynotes on topics ranging from finance and investment, regulatory, government strategy to tax. The presentations will be recorded and available to registered delegates in the days following the conference.
BioTrinity 2022 provides numerous ‘all-delegate’ networking opportunities to support knowledge sharing, future collaborations, and new business opportunities. It also features a keynote from George Freeman MP, who will provide an update on the UK Government Life Sciences Vision.
John Harris, CEO of OBN, said: “We are delighted to be hosting BioTrinity as an in-person event this year, as planned, in London and provide a platform for Life Sciences professionals to network, collaborate, partner and share industry knowledge and know-how. We would like to thank our supporters and sponsors and look forward to welcoming everyone back in-person in April, to support and catalyse growth across this exciting industry.”